Congressional Trade Leaders Call For U.S. To Raise Draft Pharma Pricing Regulation At S&ED

Congressional trade committee leaders last week called on the administration to raise at the Strategic & Economic Dialogue with China a draft policy change being floated by the Chinese Food and Drug Administration that could compel pharmaceutical companies to establish a price for drugs before they can be approved for the Chinese market. The draft change was floated informally by the Chinese government in April. “[T]he Chinese Food and Drug Administration reportedly is considering a change in policy that would...